Compare · BIOS vs BOAC
BIOS vs BOAC
Side-by-side comparison of BioPlus Acquisition Corp. (BIOS) and Bluescape Opportunities Acquisition Corp. (BOAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIOS and BOAC operate in Blank Checks (Finance), so they compete in similar markets.
- BOAC carries a market cap of $743.4M.
BioPlus Acquisition Corp.
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
Bluescape Opportunities Acquisition Corp.
Bluescape Opportunities Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Dallas, Texas.
Latest BIOS
- ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form 15-12G filed by BioPlus Acquisition Corp.
- SEC Form 25-NSE filed by BioPlus Acquisition Corp.
- SEC Form RW filed by BioPlus Acquisition Corp.
- Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
- BioPlus Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Latest BOAC
- SEC Form SC 13G/A filed by Bluescape Opportunities Acquisition Corp. (Amendment)
- Bluescape Opportunities Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form 25-NSE filed by Bluescape Opportunities Acquisition Corp.
- Bluescape Opportunities Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Bluescape Opportunities Acquisition Corp. Will Redeem its Public Shares and Will Not Consummate an Initial Business Combination
- SEC Form 10-Q filed by Bluescape Opportunities Acquisition Corp.
- SEC Form 10-Q/A filed by Bluescape Opportunities Acquisition Corp. (Amendment)
- SEC Form 10-K/A filed by Bluescape Opportunities Acquisition Corp. (Amendment)
- SEC Form 10-Q filed by Bluescape Opportunities Acquisition Corp.
- SEC Form 10-K filed by Bluescape Opportunities Acquisition Corp.